Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACT2: Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer
NCT00301925Phase 3Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- Dec 2005
- Primary completion
- Sep 2024
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, pegfilgrastim in breast cancer, sponsored by The Institute of Cancer Research. Status: unknown.
02
Drugs
capecitabinepegfilgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00301925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301925.